[EN] SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS [FR] COMPOSÉS DE TÉTRAHYDROISOQUINOLÉINE SUBSTITUÉS COMME INHIBITEURS DU FACTEUR XIA
SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20140296214A1
公开(公告)日:2014-10-02
The present invention provides compounds of Formula (I): or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.
Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10208021B2
公开(公告)日:2019-02-19
The present invention provides compounds of Formula (I):
or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.